IMNM
Immunome Inc
19.10$
-1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -98.8% | -100.0% | – | – | – | – | – | +80.3% | -16.4% | +7.3% | -73.1% | +129.7% | +23.1% | -5.9% | +6.9% | +37.2% | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -0.6% | +63.4% | -58.7% | +15.3% | -11.0% | -5.8% | +128.1% | +1,405.0% | +46.1% | -97.1% | +54.8% | +2.3% | +155.9% | -15.2% | +4.2% | +22.0% | -0.8% | +6,732.4% | -98.4% | -3.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +12.6% | -73.1% | +129.7% | +23.1% | -5.9% | +6.9% | +12.6% | -1,593.0% | – | – | – | – | |
| – | +0.0% | +7.5% | +8.9% | -13.0% | -10.5% | -13.1% | +11.6% | +7.8% | +63.4% | +39.6% | -2.8% | +84.2% | -29.2% | -8.6% | -18.6% | -8.0% | +46.1% | -33.1% | +152.1% | +59.5% | +89.2% | +27.9% | +28.7% | -23.0% | +9.7% | +21.6% | +23.5% | -23.7% | +29.1% | – | |
| – | +0.0% | +66.7% | -6.2% | +18.4% | +52.4% | +42.6% | +90.6% | -14.3% | +30.7% | +28.0% | +7.8% | +3.4% | -10.3% | +3.1% | +6.8% | -17.3% | +47.8% | +1.3% | +83.8% | -25.3% | +16.2% | +36.5% | +9.7% | +2.3% | -6.1% | +9.0% | +10.5% | +7.1% | +40.9% | – | |
| – | +0.0% | +14.8% | +6.2% | -8.1% | +2.3% | +3.8% | +44.5% | -4.3% | +47.3% | +34.5% | +1.6% | +48.6% | -23.4% | -4.4% | -8.8% | -62.5% | +47.8% | +85.9% | +1,126.1% | +35.4% | -68.2% | +26.1% | +60.4% | -44.5% | +4.6% | -78.0% | +565.7% | -19.6% | +33.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +158.8% | -50.0% | -77.3% | +100.0% | +10.0% | -90.9% | +0.0% | +200.0% | +66.7% | -80.0% | +100.0% | -50.0% | +300.0% | +4,925.0% | +7.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -2,550.0% | – | – | +800.0% | -33.3% | -116.7% | – | – | – | -132.5% | – | -575.4% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.